Stryker Gets FDA 510(k) Clearance for Q Guidance System
May 31 2022 - 9:47AM
Dow Jones News
By Chris Wack
Stryker Corp. said its Q Guidance System received 510(k)
clearance from the U.S. Food and Drug Administration.
The company said its Q Guidance System, when used with the Spine
Guidance Software, is an advanced planning and intraoperative
guidance system designed to enable open or percutaneous
computer-assisted surgery.
Stryker said the Spine Guidance Software is the first spine
navigation software to receive clearance from the FDA for use with
pediatric patients aged 13 and older.
Stryker's Q Guidance System will be used to deliver surgical
spine planning and navigation capability through multiple tracking
options, sophisticated software algorithms and smart
instrumentation, the company said.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
May 31, 2022 09:32 ET (13:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Stryker (NYSE:SYK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Sep 2023 to Sep 2024